Findings from Sun Yat-sen University Broaden Understanding of Ovarian Cancer (Loss of Hrd Functional Phenotype Impedes Immunotherapy and Can Be Reversed By Hdac Inhibitor In Ovarian Cancer).

Předmět:	OVARIAN cancer HISTONE deacetylase inhibitors IMMUNOTHERAPY PHENOTYPES
Zdroj:	Immunotherapy Weekly; 6/9/2023, p308-308, 1p
Abstrakt:	Keywords: Guangzhou; People's Republic of China; Asia; Biomarkers; Cancer; Diagnostics and Screening; Drugs and Therapies; Genetics; Gynecology; Health and Medicine; Immunotherapy; Oncology; Ovarian Cancer; Women's Health EN Guangzhou People's Republic of China Asia Biomarkers Cancer Diagnostics and Screening Drugs and Therapies Genetics Gynecology Health and Medicine Immunotherapy Oncology Ovarian Cancer Women's Health 308 308 1 06/05/23 20230609 NES 230609 2023 JUN 6 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- New research on Oncology - Ovarian Cancer is the subject of a report. The decision tree plotted on the basis of HRD and HRD-EXCUTE indicated the HRD patients without the HRD functional phenotype were largely unresponsive to immunotherapy, which was validated by the immunotherapeutic cohorts. The HRD functional phenotype HRD-EXCUTE was set up as a potent biomarker to identify whether HRD patients can benefit from immunotherapy. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu